Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
619 people get GNOM articles and Market Currents by email alert.
Get email alerts on GNOM »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Roche Is Back; Buyout Leak Is UnsurprisingPropThink • Thu, Dec 20, 2012
-
GlobeNewswire (Nov 9, 2012)
-
GlobeNewswire (Oct 18, 2012)
-
-
China Biotech In Review: China's BGI Acquires Complete GenomicsChinaBio Today • Sun, Sep 23, 2012 -
-
GlobeNewswire (Sep 17, 2012)
-
-
-
GlobeNewswire (Aug 8, 2012)
-
-
-
-
GlobeNewswire (Jul 26, 2012)
-
GlobeNewswire (Jul 24, 2012)
-
-
-
GlobeNewswire (Jul 11, 2012)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
Complete Genomics' IPO Meets With Lukewarm ReceptionThe Burrill Report • Sun, Nov 14, 2010 -
Complete Genomics Prices IPO Below RangeSA Editor Abbi Adest • Fri, Nov 12, 2010
-
-
Roche Is Back; Buyout Leak Is UnsurprisingPropThink • Thu, Dec 20, 2012
-
China Biotech In Review: China's BGI Acquires Complete GenomicsChinaBio Today • Sun, Sep 23, 2012
-
-
-
-
-
-
-
Friday Options Briefs: WMT, GNOM, ZNGAInteractive Brokers • Fri, May 25, 2012 -
-
-
-
-
6 Highly Liquid Biotech Stocks With Positive Correlation To VolatilityKapitall • Tue, Jan 31, 2012
-
-
-
Short-Sellers Expect These 14 Biotechs To OutperformKapitall • Thu, Jan 5, 2012
-
-
There are no Transcripts on GNOM.
-
at MarketWatch.com (Nov 26, 2012)
-
GlobeNewswire (Nov 9, 2012)
-
GlobeNewswire (Oct 18, 2012)
-
at MarketWatch.com (Oct 15, 2012)
-
at MarketWatch.com (Sep 17, 2012)
-
GlobeNewswire (Sep 17, 2012)
-
at Fox Business (Aug 31, 2012)
-
GlobeNewswire (Aug 8, 2012)
-
GlobeNewswire (Jul 26, 2012)
-
GlobeNewswire (Jul 24, 2012)
-
GlobeNewswire (Jul 11, 2012)
-
GlobeNewswire (Jun 19, 2012)
-
at MarketWatch.com (Jun 5, 2012)
-
GlobeNewswire (Jun 5, 2012)
-
GlobeNewswire (May 9, 2012)
-
GlobeNewswire (May 7, 2012)
-
GlobeNewswire (May 3, 2012)
-
GlobeNewswire (Mar 29, 2012)
-
at MarketWatch.com (Feb 13, 2012)
GNOM vs. ETF Alternatives
Company Description
Currently, there's no company description for GNOM.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 8, 2012, 3:57 PM Complete Genomics (GNOM -16%) drops hard after missing on its Q1 late yesterday on wider-than-expected losses. Revenue was down 42% Y/Y, largely due to an unexpected revenue recognition deferral for 200 units previously sold into Q2. Comment! [Healthcare, Earnings, On the Move]
- Thursday, March 8, 2012, 6:25 PM Complete Genomics (GNOM) reverses late session gains to trade lower in the post session after reporting a Q4 loss of $0.67 per share, compared with the prior-year period's $0.69 loss per share. Revenues were $2.5M, down 34% from $3.8M in the same quarter last year. The Street was expecting a loss of $0.65 on revenues of $3.15M. Shares -2.1% AH. Comment! [Healthcare, Earnings]
-
- View all 0 replies
-
- View all 0 replies
-
Asif Suria
Complete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge $GNOM http://bit.ly/OSEfLP - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
The Berenstain Bulls
PSTI, NBS, GNOM, and Nuvilex (NVLX) all looking swaggish as of late. http://bit.ly/P32kkI - View all 1 replies
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Michael Bryant
Now, 8 hours after close, GNOM is up in still afterhours, but only 8%. Sounds like a lot of investors are cashing in. Maybe you should too. - View all 0 replies
LATEST REPLIES
-
Michael Bryant
Complete Genomics (GNOM) and its DNA sequencing technology looks good. But Neostem (NBS) and stem cells...no. http://yhoo.it/KSyRFj - View all 6 replies
-
-
The Berenstain Bulls: @Maria: Yeah, I like GNOM as well, currently long a few shares.
-
The Berenstain Bulls
PSTI, NBS, GNOM, and Nuvilex (NVLX) all looking swaggish as of late. http://bit.ly/P32kkI - View all 1 replies
-
-
- View all 2 replies
-
-
-
- View all 6 replies
-
John Motyka: Michael: Go to singularityhub.com for free newsletter. Rich source of stem cell news including recent Lancet article plus many others...jdm -
-
- View all 3 replies
-
-
-
- View all 4 replies
-
-
-
- View all 6 replies
-
-